IP Library Granted Patent US 10,226,437
Granted Patent B2
US 10,226,437 · App. 15/803,279 · Granted Mar 12, 2019

Materials and methods for controlling infections

Inventors: Carolyn L. Twomey (Lawrenceville, GA); Gareth Clarke (Lawrenceville, GA); Samuel J. Zaidspiner (Lawrenceville, GA)
Assignee: INNOVATION TECHNOLOGIES, INC.
A61K31/155A61F13/00063A61K9/0019A61K9/0043A61K9/0073A61K9/0085A61K9/08A61K31/191A61K45/06A61L15/44A61L17/005A61L27/54A61L29/08A61L29/16A61L31/08A61L31/16A61M25/0017A61K2300/00A61L2300/206
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,226,437
App. No.
15/803,279
Granted
Mar 12, 2019
Kind
B2
Abstract

The subject invention provides materials methods for reducing infections in subjects. The materials methods utilize chlorhexidine, which has been found to be surprisingly non-toxic. The lack of toxicity facilitates the use of chlorhexidine in contexts that were not previously thought to be possible.

Claims (11)

1. A method for reducing infection at a site in a subject, wherein said method comprises administering to the site an aqueous solution that comprises chlorhexidine at a concentration of 0.05% or less, and wherein the site is the colon.

2. The method of claim 1 , wherein the chlorhexidine is chlorhexidine gluconate.

3. The method of claim 1 , further comprising applying suction to the site.

4. The method of claim 1 , wherein chlorhexidine is administered to the site via a sustained release material containing the chlorhexidine.

5. The method of claim 1 , used to inhibit the growth of biofilm.

6. A method for reducing infection at a site in a subject, wherein said method comprises administering to the site a formulation that comprises an aqueous solution of chlorhexidine at a concentration of 0.05% or less, wherein the site is the colon and wherein the method further comprises applying suction to the site.

7. The method of claim 6 , wherein the chlorhexidine is chlorhexidine gluconate.

8. The method of claim 6 , used to inhibit the growth of biofilm.

9. A method for reducing infection at a site in a subject, wherein said method comprises administering to the site a formulation that consists of an aqueous solution of chlorhexidine at a concentration of 0.05% or less, and, optionally, a buffer, wherein the site is the colon.

10. The method of claim 9 , wherein the chlorhexidine is chlorhexidine gluconate.

11. The method of claim 9 , used to inhibit the growth of biofilm.

Assignments (2)
SECURITY INTEREST Recorded Aug 21, 2024
From: INNOVATION TECHNOLOGIES, INC.
To: OXFORD FINANCE LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 068360/0957 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2017
From: TWOMEY, CAROLYN L.; CLARKE, GARETH; ZAIDSPINER, SAMUEL J.
To: INNOVATION TECHNOLOGIES, INC.
Reel/Frame 044056/0014 →
Continuity (4)
Continuation 15173089 · Jun 3, 2016
Continuation 14568925 · Dec 12, 2014
Provisional Application 61915281 · Dec 12, 2013
Related Publication 20180055794A1 · Mar 1, 2018